Product NDC: | 43975-226 |
Proprietary Name: | Granisetron hydrochloride |
Non Proprietary Name: | Granisetron hydrochloride |
Active Ingredient(s): | 1 mg/1 & nbsp; Granisetron hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43975-226 |
Labeler Name: | Amerigen Pharmaceuticals, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078969 |
Marketing Category: | ANDA |
Start Marketing Date: | 19950316 |
Package NDC: | 43975-226-81 |
Package Description: | 1 BLISTER PACK in 1 PACKAGE (43975-226-81) > 2 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Code | 43975-226-81 |
Proprietary Name | Granisetron hydrochloride |
Package Description | 1 BLISTER PACK in 1 PACKAGE (43975-226-81) > 2 TABLET, FILM COATED in 1 BLISTER PACK |
Product NDC | 43975-226 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Granisetron hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19950316 |
Marketing Category Name | ANDA |
Labeler Name | Amerigen Pharmaceuticals, Inc |
Substance Name | GRANISETRON HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |